Bristol-Myers Squibb

Random entry RSS

Posted in:
Legal

Amicus Brief Filed By Biopharmaceutical Companies in Support of Amgen’s Petition for Rehearing En Banc
By Nicole DeAbrantes January 22, 2018 Comments are off
On December 20, 2017, Bristol Myers Squibb Company, Bavarian Nordic, and Enzo Biochem, Inc. filed an amicus brief in support of Amgen’s...

Read more

Tagged with: Amgen, Amicus Brief, Bavarian Nordic, Bristol-Myers Squibb, District Court, En banc, Enzo Biochem, Federal Circuit, Inc., Praluent®, Regeneron, Sanofi

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:
Legal

Standing Questioned Before the Federal Circuit in Momenta Pharms. v. Bristol-Myers Squibb Co.
By Nicole DeAbrantes January 5, 2018 Comments are off
On December 5, 2017, the Federal Circuit held oral argument in Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company, 17-1694. The...

Read more

Tagged with: abatacept, Bristol-Myers Squibb, Federal Circuit, IPR, Momenta Pharmaceuticals, Orencia®, PTAB

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top